Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | PREJFPARTNERRE LTD |
|---|---|
| Last close | no stored close |
| Change % | no stored close |
| Market cap | no stored close |
| P/E | no stored close |
| Revenue | $5.4B⊙INFERENCE — derived by arithmetic SourceSEC XBRL companyfacts FieldRevenues As ofTTM ending 2016-03-31 Filing10-Q · 0000911421-16-000093 · filed 2016-05-02 HowSum of the last four filed quarters: arithmetic on filed figures, no estimates. |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Each cell names its period. A ratio row reads not comparable when the companies’ periods differ by more than six weeks or mix a fiscal year with a trailing twelve months, and a figure more than a year older than the company’s newest period is marked older period. No row ranks the companies. Educational only, not investment advice. Not assessed. The F-, Z- and M-Scores were all derived on non-financial companies and their authors excluded financials. For an insurer they measure the shape of the business, not its health. We would rather report nothing than report a number that does not transfer.
| Rev growth (YoY) | -16.1%TTM to 2016-03-31 |
| Net income | $75M⊙INFERENCE — derived by arithmetic SourceSEC XBRL companyfacts FieldNetIncomeLoss As ofTTM ending 2016-03-31 Filing10-Q · 0000911421-16-000093 · filed 2016-05-02 HowSum of the last four filed quarters: arithmetic on filed figures, no estimates. Open the filing on EDGAR →Open the XBRL payload →CitePARTNERRE LTD (PREJF), us-gaap:NetIncomeLoss: 74,626,000 USD, trailing twelve months ended 2016-03-31, the sum of four filed quarters. Newest quarter from Form 10-Q, accession 0000911421-16-000093, filed 2016-05-02. Source: SEC EDGAR XBRL companyconcept, https://data.sec.gov/api/xbrl/companyconcept/CIK0000911421/us-gaap/NetIncomeLoss.json |
| Net margin | 1.4%TTM to 2016-03-31 |
| EPS (diluted) | no EPS filed |
| Piotroski F-ScoreUNVALIDATED | Not assessed |
| Altman Z-ScoreUNVALIDATED | Not assessed |
| Beneish M-ScoreUNVALIDATED | Not assessed |
| Next earnings | rep. 05-02 |